New York, New York--(Newsfile Corp. - January 14, 2026) - OS Therapies Inc. ("OS Therapies" or "the Company"), the world leader in listeria-based cancer immunotherapies, today announced that its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results